Medical Device News Magazine

Stephanie Ailey Named DM Clinical Research Vice President of Business Development

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

DM Clinical Research has hired industry veteran Stephanie Ailey as Vice President of Business Development, bringing more than 20 years of program management and healthcare experience to the national clinical trial site network.

“Stephanie has a great track record building strategic relationships that help advance medical research,” said Mohammad Millwala, CEO & Founder of DM Clinical Research. “Our site network has been growing rapidly over the last three years and Stephanie will be an important part of our success going forward. DM Clinical Research expects to launch several new sites before the end of the year and Stephanie’s expertise will be vital to ensuring success as we enter new markets.”

Stephanie Ailey previously served as Vice President of Business Development with both Velocity Clinical Research and Meridian Clinical Research. She also served as Meridian’s Senior Director of Business Development, Director of Business Development, and Director of Operations.

“I love research and had the unique experience of working at the study site that enrolled the first patient globally to participate in a Phase 3 COVID-19 trial,” said Ailey. “I was attracted to DM Clinical Research because of Mohammad and his vision for the company. The commitment Mohammad has shown to not only diversity in clinical trials, but diversity among the staff and primary investigators is inspirational.”

While many study sites and clinical research sponsors continue to struggle to ensure diversity, 48.5% of all participants in DM Clinical Research studies in 2022 identified as diverse. In 2022, the company reported minority enrollment of 50.41% in vaccine studies. DM Clinical Research’s leadership team and employees are also extremely diverse with roughly 75 percent of the company’s more than 600 employees identifying as diverse.

Originally from Oklahoma, Ailey now resides in Savannah, Georgia. Earlier in her career, she served as a Program Manager with the University of Oklahoma and a Child Welfare Specialist with the Oklahoma Department of Human Services. Ailey received a Citation of Appreciation from the Oklahoma State Legislature in recognition of her volunteer work. She earned a Bachelor’s in Communication from Southwestern Adventist University.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”